What is Alkermes's free cash flow?

Alkermes (ALKS) reported free cash flow of -$169.83M in Q1 2026.

How has Alkermes's free cash flow changed year-over-year?

Alkermes's free cash flow decreased by 291.5% year-over-year, from $88.7M to -$169.83M.

What is the long-term trend for Alkermes's free cash flow?

Over 4 years (2021 to 2025), Alkermes's free cash flow has grown at a 59.8% compound annual growth rate (CAGR), from $73.7M to $480.33M.

Alkermes ALKS Free cash flow

Free cash flow at other companies

Bristol-Myers SquibbBMY

$757M-55.3%

AbbVieABBV

$3.56B+155%

Jazz PharmaceuticalsJAZZ

——

Axsome TherapeuticsAXSM

——

Ionis PharmaceuticalsIONS

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$392.9M+28.2%

Gross profit$331.3M+28.8%

Operating income-$48.3M-450%

Net income-$66.5M-396%

EPS (diluted)-$0.40-408%

Balance sheet

See full

Cash & equivalents$351.6M-12.1%

Total debt$1.6B+2,034%

Total equity$1.8B+15.9%

Total assets$4.3B+105%

Cash flow

See full

Operating cash flow-$165.7M-268%

CapEx$4.1M-59.5%

Valuation

See full

Market cap$7.5B+9.7%

Enterprise value$8.73B+41.2%

P/E49.1×+29.7×

P/S4.8×+0.3×

Profitability

See full

Gross margin86.6%+2.2pp

Operating margin12.3%-13.6pp

Net margin9.8%-13.5pp

FCF margin14.2%-17.6pp

Returns & leverage

See full

Return on equity9.4%-16.1pp

Debt / equity0.9×+0.9×

Current ratio2.3×-1.1×

Where this comes from

Calculated from Alkermes’s reported figures.

−$165.7Mnet cash from operating−$4.1Mcapital expenditures=-$169.83M

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alkermes's free cash flow?: Alkermes (ALKS) reported free cash flow of -$169.83M in Q1 2026.
How has Alkermes's free cash flow changed year-over-year?: Alkermes's free cash flow decreased by 291.5% year-over-year, from $88.7M to -$169.83M.
What is the long-term trend for Alkermes's free cash flow?: Over 4 years (2021 to 2025), Alkermes's free cash flow has grown at a 59.8% compound annual growth rate (CAGR), from $73.7M to $480.33M.